Drugs / TONKA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03216668 | Jun 2017 → Jun 2019 | liver failure | Nhat Nhat Pharmaceutical Company | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TONKA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03216668 ↗ |
| Route | Oral | “Administered orally twice a day, 2 tablets each time, for 6 weeks.” NCT03216668 ↗ |